Broussonin A Attenuates Type 2 Diabetic Osteoporosis by Reactivating JAK2/STAT3 Signaling to Inhibit Ferroptosis in BMSCs
{{output}}
Type 2 diabetic osteoporosis (T2DOP) significantly impairs bone health, partially through ferroptosis triggered by glucolipotoxicity. However, therapeutic strategies targeting this process remain largely unexplored. Broussonin A (BRA), a natural antioxidant co... ...
